Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning

Metformin is a first-line drug used for the treatment of type 2 diabetes. Recently, metformin has been reported to reduce the carcinogenic risk and inhibit tumor cell growth in glioma and breast cancer. The anticancer action of metformin involves the enhancement of phosphorylation of liver kinase B1...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Lett
Main Authors: IRIE, HARUKO, BANNO, KOUJI, YANOKURA, MEGUMI, IIDA, MIHO, ADACHI, MASATAKA, NAKAMURA, KANAKO, UMENE, KIYOKO, NOGAMI, YUYA, MASUDA, KENTA, KOBAYASHI, YUSUKE, TOMINAGA, EIICHIRO, AOKI, DAISUKE
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2016
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4734273/
https://ncbi.nlm.nih.gov/pubmed/26893732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4075
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados